Avenue Capital Group

Voom Medical Devices specializes in manufacturing innovative orthopedic medical devices and appliances, primarily focused on minimally invasive surgery for the foot and ankle. Their product portfolio includes orthopedic devices designed to surgically repair bunions while preserving a range of motion, aiming to enhance patients' quality of life. Additionally, they provide tools to facilitate bone surgery, enabling healthcare professionals to improve surgical efficiency.

Spectral AI, Inc. is a predictive analytics company specializing in advanced optical technology and artificial intelligence for wound healing predictions. The company has developed the DeepView® Wound Imaging Solution, a proprietary multispectral imaging system that has received FDA Breakthrough Designation for its application in assessing burn wounds. This innovative technology enables clinicians to differentiate between non-healing and healing human tissue that is typically invisible to the naked eye. By providing 'Day One' healing assessments for conditions such as burn wounds and diabetic foot ulcers, Spectral AI aims to enhance the accuracy and speed of treatment decisions in the wound care sector.

Proscia Inc., established in 2014 and headquartered in Philadelphia, Pennsylvania, specializes in digital pathology informatics through its innovative cloud-based platform. This platform aids in routine pathology operations, enhances cancer diagnosis, and seeks to improve patient outcomes. By leveraging advanced computing technologies, Proscia's solution unlocks hidden data that is not discernible to the human eye, transforming that information into valuable insights. These insights support physicians in accelerating the development of life-saving medical advances, ultimately contributing to a more effective diagnostic process in the field of pathology.

CalciMedica, Inc. is a clinical-stage biopharmaceutical company based in La Jolla, California, specializing in the discovery and development of small molecule drugs aimed at treating autoimmune and inflammatory diseases. Founded in December 2006 by a team of scientists with backgrounds in the field, the company focuses on the specific inhibition of calcium release-activated calcium channels. This innovative approach seeks to modulate the immune response and protect against tissue cell injury, addressing significant unmet medical needs in life-threatening inflammatory conditions for which existing therapies are lacking. CalciMedica's proprietary technology has the potential to offer therapeutic benefits in these challenging areas of healthcare.

Men in Blazers is a U.S.-based media company specializing in soccer coverage. It produces engaging content, including podcasts and TV shows, focused on major international leagues like the Premier League and Champions League, as well as U.S. national teams and the National Women's Soccer League. The company is known for its unique blend of humor, emotion, intelligence, and pop culture references in its coverage.

Mercury/13, established in 2023, is a private equity firm specializing in acquiring equity stakes in European professional women's football teams. Its primary objective is to become a leading force in women's football ownership by strategically investing in and supporting the growth of future powerhouse clubs, thereby tapping into the vast, underserved market of women's football fans.

Unrivaled is a professional women's basketball league dedicated to promoting female athletes through an innovative competition platform. The league focuses on providing an alternative source of competition and income for players during the WNBA offseason. Unrivaled organizes three-on-three basketball matches, creating a unique and engaging format that highlights the skills and talents of women in sports. This initiative not only fosters a competitive environment but also aims to enhance the visibility and opportunities for female athletes in the basketball community.

Ocugen, Inc. is a clinical-stage biopharmaceutical company based in Malvern, Pennsylvania, dedicated to discovering, developing, and commercializing innovative therapies aimed at curing blinding diseases. The company's pipeline includes several promising product candidates, such as OCU200, a novel fusion protein in preclinical development for treating wet age-related macular degeneration (AMD), diabetic retinopathy, and diabetic macular edema. Additionally, Ocugen is developing OCU400 for retinitis pigmentosa, a rare genetic disorder, and OCU410 for dry AMD. The company utilizes its Modifier Gene Therapy Platform to address unmet medical needs in the field of retinal diseases, including inherited conditions and multifactorial diseases. Ocugen has also established a strategic partnership with CanSino Biologics Inc. for the co-development and manufacturing of gene therapies.

Epica International, Inc. specializes in designing, developing, and distributing innovative robotic systems that integrate advanced imaging technology and precision robotics. The company offers a range of products, including Vimago, a CT imaging and fluoroscopy device for veterinary diagnostics; Pegaso, a high-definition CT system for equine applications; and Artemis, a device for non-invasive regenerative therapy. Additionally, Epica provides Ortis, a robotic system for orthopedic carving, SandRob for surface processing needs, ScultoRob for milling artistic designs, and ARPP, a software for robotic simulation and control. Established in 2013 and headquartered in San Clemente, California, Epica serves various markets, including veterinary medicine, orthotics and prosthetics, and surface processing, aiming to enhance treatment outcomes through the integration of imaging and robotics.

Cosm is a technology, media, and entertainment company that specializes in creating comprehensive solutions for immersive experiences across various sectors. The company develops a global platform that integrates physical design, engineering, manufacturing, software, and content delivery, enabling large-scale, live immersive entertainment. By focusing on areas such as sports, education, and attractions, Cosm aims to transform how individuals engage with entertainment through innovative technologies and experiences.

Cytosorbents Corporation is a critical care-focused therapeutic device company based in Monmouth Junction, New Jersey. The company specializes in blood purification technologies aimed at treating life-threatening conditions, particularly in intensive care and cardiac surgery settings. Its flagship product, the CytoSorb device, is an extracorporeal cytokine filter designed to reduce inflammation and prevent multiple organ failure in critical illnesses such as sepsis and trauma. The technology utilizes biocompatible, highly porous polymer beads capable of removing toxic substances from blood through pore capture and surface adsorption. In addition to CytoSorb, the product portfolio includes devices like VetResQ for veterinary applications, HemoDefend for blood purification, and DrugSorb for removing toxic chemicals from the bloodstream. Cytosorbents generates revenue primarily from product sales in Germany and also receives funding from U.S. grant agencies. The company was founded in 1997 and was previously known as MedaSorb Technologies Corporation before rebranding in 2010.

NSP is a restaurant brand that specializes in providing franchising solutions for Burger King, KFC, and other fast-food restaurants.

PolarityTE, Inc. is a clinical-stage biotechnology company based in Salt Lake City, Utah, specializing in regenerative medicine. Founded in 2015, the company focuses on developing functionally polarized human tissues to enhance clinical medicine and biomedical research. PolarityTE's innovative technology platform enables the regeneration of tissues using the patient’s own cells, promoting natural healing processes. One of its flagship products, SkinTE, is designed to repair and regenerate skin for patients suffering from acute and chronic wounds, burns, and other conditions requiring surgical reconstruction. The company emphasizes the use of autologous tissue to create dynamic, self-propagating products that facilitate effective regenerative healing, thereby transforming the landscape of tissue engineering and regenerative therapies.

ProducePay, founded by Pablo Borquez Schwarzbeck, is an AgTech company dedicated to transforming the fresh produce supply chain. By addressing the economic and food waste caused by its volatility and fragmentation, ProducePay offers a Predictable Commerce Platform that enhances connectivity between growers and buyers. This platform provides farmers with immediate access to financing, liquidity, and real-time pricing data, fostering transparency and enabling efficient business operations. Additionally, it facilitates connections with key industry players, allowing farmers to access tailored cash flow services. Through these innovations, ProducePay is committed to delivering fresher produce to consumers while promoting sustainable practices within the global fresh produce industry.

ITS Technology Group Limited is a telecommunications and IT services provider based in Chester, United Kingdom, with additional offices in Cleveland, Glasgow, West Yorkshire, and Powys. Established in 2013, the company specializes in delivering internet and managed IT services to rural and urban businesses, communities, and regions. Its offerings include a range of broadband solutions such as wireless WAN, full fiber services, and WiFi hotspots, alongside telecommunications services like VoIP and business lines. Additionally, ITS provides managed IT services encompassing Microsoft Office 365, cloud storage, LAN infrastructure, and consultancy. The company focuses on enhancing connectivity and operational efficiency for both private and public sector organizations through strategic partnerships.

Beyond Air, Inc. is a clinical-stage medical device and biopharmaceutical company based in Garden City, New York, focused on developing inhaled nitric oxide (NO) therapies for respiratory infections and solid tumors. The company is advancing its proprietary LungFit system, a nitric oxide generator and delivery device designed to provide precise amounts of NO to patients, whether intubated or non-intubated, in both hospital and home settings. This innovative technology generates nitric oxide from ambient air, allowing for continuous or intermittent delivery and enabling on-demand titration. Beyond Air aims to transform the treatment landscape for respiratory conditions, targeting various ailments such as lung infections, persistent pulmonary hypertension in newborns, and severe respiratory illnesses. Founded in 2011, the company strives to improve patient outcomes while addressing the need to eliminate traditional gas cylinders from medical environments.

Eyenovia, Inc. is a clinical-stage ophthalmic biopharmaceutical company based in New York, specializing in the development of innovative microdose therapeutics through its proprietary piezo-print delivery technology called the Optejet. Founded in 2014, Eyenovia aims to transform the delivery of ophthalmic therapies by providing high-precision, targeted administration of medications, which has the potential to replace traditional eye droppers and enhance safety, tolerability, and patient compliance. The company is advancing several product candidates, including MicroLine for presbyopia, MicroProst for chronic angle closure glaucoma and other conditions, MicroStat for mydriasis, MicroTears for red eye and itch relief, and MicroPine for progressive myopia. Eyenovia focuses on developing treatments for ophthalmic diseases where no FDA-approved therapies currently exist, contributing to its goal of improving patient care in the field of eye health.

Kin Insurance, Inc. is a digital insurance agency that specializes in homeowners insurance and related products. Founded in 2016 and headquartered in Chicago, Illinois, with an additional office in St. Petersburg, Florida, the company aims to enhance the convenience and affordability of insurance by operating directly with consumers, eliminating the need for external agents. Kin Insurance offers a variety of products, including homeowners, mobile home, condo, flood, and landlord insurance, among others. The company leverages extensive property data to ensure precise pricing and improve underwriting outcomes, providing personalized coverage options and efficient claims services through its technology-driven platform.

Oliver Space is a home furnishing company founded in 2018 in San Francisco, California, by Chan Park. The company specializes in providing a wide range of furniture and home decor products, including sofas, rugs, pillows, and plants, through an online platform. Oliver Space offers customers a flexible payment structure, allowing them to rent or buy items on a monthly subscription basis with the option to try before they commit, all at 0% interest. This approach enables customers to create appealing living spaces without financial strain, making home decoration both accessible and affordable.

Enerkem Inc. is a Canadian cleantech company based in Montreal, specializing in the production of renewable biofuels and chemicals from non-recyclable municipal solid waste. Founded in 2000, Enerkem has developed a proprietary thermochemical technology that efficiently converts waste into biofuels, primarily cellulosic ethanol, and renewable chemicals. This patented process chemically recycles the carbon in waste materials, creating a synthesis gas that is transformed into biofuels and chemicals using commercially available catalysts. With a focus on addressing the challenges of oil dependence and waste disposal, Enerkem aims to produce these renewable products at commercial scale. The company has undertaken extensive validation of its technology over a decade, utilizing solid waste from various municipalities. Enerkem employs around 170 people across Canada and the United States and has established strategic partnerships to support its mission of advancing sustainable energy solutions.

Aytu Biopharma is a specialty pharmaceutical company focused on developing and commercializing products for various healthcare conditions. The company primarily targets urological indications, with an emphasis on male sexual dysfunction and male infertility, while exploring opportunities in other related areas. In addition to its urological focus, Aytu Biopharma offers prescription therapeutics for attention deficit hyperactivity disorder and other common pediatric conditions. The company is also advancing a therapeutic pipeline that includes AR101/enzastaurin, a prospective treatment for vascular Ehlers-Danlos Syndrome, a rare genetic disorder characterized by serious health complications. This treatment has received Orphan Drug designation from the FDA, highlighting its potential importance in addressing unmet medical needs. Aytu Biopharma’s diverse portfolio reflects its commitment to improving patient outcomes across various therapeutic areas.

Intellihot is a manufacturer of tankless water heater systems for both residential and commercial applications. Established in 2005, the company emerged from the founder's experience with a traditional water heater malfunction. Intellihot's innovative designs, which have several patents pending, focus on conserving space and eliminating the need for bulky storage tanks. The systems are equipped with advanced connectivity features, including Wi-Fi and 3G/4G capabilities, allowing users to connect to a router or internet hub. This connectivity enables the analysis of water usage patterns, providing clients with on-demand water heating solutions that are both efficient and space-saving.

BioVie Inc. is a clinical-stage biotechnology company based in Santa Monica, California, focused on discovering, developing, and commercializing innovative drug therapies for chronic and debilitating conditions, particularly liver disease and neurological disorders. Founded in 2013 and previously known as NanoAntibiotics, Inc., BioVie is advancing its lead product, BIV201, which has completed a Phase 2a clinical trial aimed at treating ascites resulting from chronic liver cirrhosis. Additionally, the company is conducting a pivotal Phase 3 study of NE3107 to assess its efficacy in patients with mild to moderate Alzheimer's disease. BioVie aims to improve the health and quality of life for patients through its targeted therapies.

Netomnia is a fiber-to-the-premises (FTTP) broadband service provider based in London, England, established in 2019. The company focuses on constructing full-fiber broadband infrastructure and networks throughout the United Kingdom, aimed at connecting both homes and businesses. By offering symmetrical multi-gigabit services, Netomnia ensures that clients receive reliable internet speeds tailored to their specific requirements.

Delcath Systems, Inc. is an interventional oncology company based in New York that specializes in the treatment of primary and metastatic liver cancers. The company's primary product is Melphalan Hydrochloride for Injection, which is combined with the Delcath Hepatic Delivery System to deliver high-dose chemotherapy directly to the liver while minimizing systemic exposure and side effects. Delcath is currently conducting Phase III clinical trials, including the FOCUS Trial for patients with hepatic dominant ocular melanoma and the ALIGN Trial for intrahepatic cholangiocarcinoma. In addition to its clinical efforts, the company markets Melphalan Hydrochloride under the Delcath Hepatic CHEMOSAT Delivery System in Europe. Founded in 1988, Delcath Systems is dedicated to advancing treatment options for patients with liver cancer.

Cytocom, Inc. a specialty biotech company, founded by patients, specializing in repurposing of drugs that deploys their patented therapies focused on the activation and rebalancing of the body’s immune system. Stimulating the body’s immune system remains one of the most promising approaches in the treatment of Cancers, HIV, Autoimmune Diseases, inflammatory conditions and other chronic infectious diseases.

Third Pole Therapeutics, based in Waltham, Massachusetts, specializes in developing innovative, on-demand nitric oxide delivery systems for various medical applications. Their core technology generates pure, inhalable nitric oxide from air and electricity, eliminating the need for bulky gas cylinders. This system is equivalent to traditional tank-gas methods and has proven effective in treating hypoxic respiratory failure in newborns. The company aims to expand the accessibility of nitric oxide therapy, which is currently limited to certain countries and healthcare settings, to save lives and improve patient outcomes in conditions like malaria, heart attacks, and strokes.

Zorin Finance is a real estate lender established in 2011 and headquartered in London, United Kingdom. The company specializes in offering development finance and bridge loans specifically tailored for real estate developers operating within the UK market. By focusing on the needs of the real estate sector, Zorin Finance aims to support developers in achieving their project goals through accessible and targeted financial solutions.

Castlehaven Finance is an alternative lender that specializes in funding property development projects throughout Ireland. The company provides a range of lending services, including senior development loans, bridge finance, and financing for residential, commercial, and mixed-use developments. Its focus is on supporting private, social, and commercial initiatives, ensuring that clients have access to flexible and reliable loan options tailored to their specific needs.

Asset Reconstruction Company (India) Ltd. is a Mumbai-based entity specializing in asset reconstruction and management services. The company focuses on the acquisition of non-performing financial assets from Indian banks and financial institutions, facilitating the resolution of significant amounts of Non-Performing Assets (NPAs). By establishing trusts and special purpose vehicles (SPVs), it assists these institutions in maintaining liquidity and operational efficiency, thereby enabling them to achieve their financial objectives. Since its inception, Asset Reconstruction Company has successfully resolved over Rs. 780 billion worth of NPAs, positioning itself as a key player in the financial services sector in India.

Owns and operates a coal-fired power plant near Baltimore

Ambow Education Holding Ltd. is a prominent provider of educational and career enhancement services in the People's Republic of China. The company operates through two main segments: K-12 Schools and Career Programs and Continuing Education (CP&CE). The K-12 Schools segment offers educational services that encompass K-12 programs, tutoring, and international education. The CP&CE segment focuses on tutoring centers that provide classroom instruction, small group, and individualized tutoring to help students excel in their studies and prepare for critical examinations, such as high school and university entrance tests. Additionally, this segment offers educational software, career enhancement services, and training for both professional and soft skills, including leadership and interview techniques. As of December 31, 2019, Ambow operated 60 centers and schools, which included K-12 schools, tutoring centers, training offices, and career enhancement facilities. Founded in 2000 and headquartered in Beijing, Ambow aims to meet the growing educational demands of students and recent graduates in China.

Wuxi Qiaolian Wind Power Technology Co. Ltd. is a manufacturer based in Wuxi, China, established in 2006. The company specializes in the design, research, and production of wind power equipment accessories, including rotor hubs, nacelle bases, girder systems, bearing cases, and pitch adjuster parts. In addition to wind power equipment, Wuxi Qiaolian also focuses on the manufacture of CNC and general-purpose machine tools, as well as metallurgical equipment. The company's diverse offerings position it as a key player in the renewable energy sector, contributing to the advancement of wind power technology.

Ambow Education Holding Ltd. is a prominent provider of educational and career enhancement services in the People's Republic of China. The company operates through two main segments: K-12 Schools and Career Programs and Continuing Education (CP&CE). The K-12 Schools segment offers educational services that encompass K-12 programs, tutoring, and international education. The CP&CE segment focuses on tutoring centers that provide classroom instruction, small group, and individualized tutoring to help students excel in their studies and prepare for critical examinations, such as high school and university entrance tests. Additionally, this segment offers educational software, career enhancement services, and training for both professional and soft skills, including leadership and interview techniques. As of December 31, 2019, Ambow operated 60 centers and schools, which included K-12 schools, tutoring centers, training offices, and career enhancement facilities. Founded in 2000 and headquartered in Beijing, Ambow aims to meet the growing educational demands of students and recent graduates in China.